9926:HKG
Akeso Inc
91,30 HK$
arrow_upward
+0,94%(+0,85) 1D
16 հոկ, 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
92,15 HK$
High
95,30 HK$
Low
90,15 HK$
Mkt. cap
84,10 մլրդ
Avg. vol.
10,45 մլն
Volume
11,09 մլն
52-wk high
156,00 HK$
52-wk low
80,20 HK$
EPS
-1,24 HK$
No. of employees
4 հզր
Open
92,15 HK$
High
95,30 HK$
Low
90,15 HK$
Mkt. cap
84,10 մլրդ
Avg. vol.
10,45 մլն
Volume
11,09 մլն
52-wk high
156,00 HK$
52-wk low
80,20 HK$
EPS
-1,24 HK$
No. of employees
4 հզր
News stories
From web sources and news partners
Kalkine Media
·
34 րոպե առաջ
Why is Enphase Energy (NASDAQ:ENPH) back in the spotlight today?
TradingView
·
1 ժամ առաջ
Nasdaq Futures Rebound 1% as Oil Falls and Tech Earnings Loom. What to Watch This Week.
MarketBeat
·
40 րոպե առաջ
1stdibs.com (NASDAQ:DIBS) Stock Rating Cut to Hold at Wall Street Zen
Bloomberg.com
·
8 ժամ առաջ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4,08 հզր
Founded19 մրտ, 2012 թ.
Headquarters-
Sector-
Websiteakesobio.com